Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$1.27B |
| 2 |
SNDK
Sandisk
SNDK
|
+$674M |
| 3 |
Credo Technology Group
CRDO
|
+$476M |
| 4 |
NBIS
Nebius Group N.V.
NBIS
|
+$452M |
| 5 |
Vertiv
VRT
|
+$420M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.98B |
| 2 |
Amazon
AMZN
|
+$1.25B |
| 3 |
Shopify
SHOP
|
+$1.08B |
| 4 |
Edwards Lifesciences
EW
|
+$1.07B |
| 5 |
Microsoft
MSFT
|
+$630M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 43.11% |
| 2 | Communication Services | 13.94% |
| 3 | Consumer Discretionary | 10.64% |
| 4 | Industrials | 9.08% |
| 5 | Healthcare | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
TeraWulf
WULF
$7.66B
| $110M | 0.07% |
4,469,069
+767,174
| +21% | +$17.6M |
|
152
IBM
IBM
$222B
| $110M | 0.07% |
389,932
-246,326
| -39% | -$62.1M |
|
153
Quanta Services
PWR
$90.6B
| $109M | 0.07% |
152,041
+25,341
| +20% | +$17.3M |
|
|
AAMI
154
Acadian Asset Management
AAMI
$3.4B
| $109M | 0.07% |
1,526,570
-495,637
| -25% | -$34.5M |
|
155
Urban Edge Properties
UE
$2.7B
| $109M | 0.07% |
4,757,938
+172,682
| +4% | +$3.81M |
|
156
Elbit Systems
ESLT
$33.2B
| $109M | 0.07% |
143,473
-7,436
| -5% | -$6.18M |
|
157
Semtech
SMTC
$12.2B
| $108M | 0.06% |
667,291
-77,089
| -10% | -$10.1M |
|
158
Intel
INTC
$473B
| $108M | 0.06% |
+772,639
| New | +$78.1M |
|
159
TechnipFMC
FTI
$29.7B
| $106M | 0.06% |
1,599,692
+11,168
| +0.7% | +$791K |
|
160
Heritage Financial
HFWA
$1.17B
| $105M | 0.06% |
3,538,159
+324,686
| +10% | +$8.93M |
|
161
Tarsus Pharmaceuticals
TARS
$3.15B
| $105M | 0.06% |
1,663,655
-48,469
| -3% | -$3.1M |
|
162
MACOM Technology Solutions
MTSI
$20.3B
| $103M | 0.06% |
269,632
-30,093
| -10% | -$9.98M |
|
163
Stryker
SYK
$127B
| $102M | 0.06% |
+323,435
| New | +$102M |
|
164
Generac Holdings
GNRC
$10.8B
| $102M | 0.06% |
347,460
-173,168
| -33% | -$43.4M |
|
165
Regal Rexnord
RRX
$10.5B
| $101M | 0.06% |
422,076
+58,958
| +16% | +$12.3M |
|
166
Burlington
BURL
$17.1B
| $100M | 0.06% |
316,336
-10,264
| -3% | -$3.31M |
|
167
Dianthus Therapeutics
DNTH
$5.92B
| $99.6M | 0.06% |
1,021,763
+536,627
| +111% | +$46.9M |
|
168
CVS Health
CVS
$119B
| $97.5M | 0.06% |
942,869
+14,816
| +2% | +$1.32M |
|
|
BELFB
169
Bel Fuse Inc Class B
BELFB
$3.59B
| $97.3M | 0.06% |
+292,065
| New | +$78.9M |
|
|
CON
170
Concentra Group Holdings
CON
$4.37B
| $96.9M | 0.06% |
3,256,435
+1,084,144
| +50% | +$27M |
|
171
Insmed
INSM
$25.9B
| $96.5M | 0.06% |
905,094
+300,400
| +50% | +$36.4M |
|
172
Corning
GLW
$128B
| $95.1M | 0.06% |
372,407
+39,135
| +12% | +$7.12M |
|
173
Flywire
FLYW
$2.29B
| $92.6M | 0.06% |
5,272,962
-25,919
| -0.5% | -$383K |
|
|
PR
174
Permian Resources
PR
$19B
| $92.5M | 0.06% |
5,025,209
-1,204,825
| -19% | -$24.2M |
|
|
MANE
175
Veradermics Inc
MANE
$4.09B
| $92M | 0.06% |
748,678
+606,897
| +428% | +$56.9M |
|
Similar funds
Jennison Associates's Q2 2026 Portfolio in Review
As of Q2 2026, Jennison Associates held 641 positions worth $167B, up 15% from $145B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Jennison Associates withdrew a net $6.22B in Q2 2026, closing 74 positions and reducing 282 holdings. Its most notable exit was Gilead Sciences, an estimated $176M position sold in full.
By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 39% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Jennison Associates opened a new position in SpaceX worth $1.27B.
- Jennison Associates's largest Q2 2026 buy was SpaceX: 7,448,891 shares worth $1.27B.
- Jennison Associates added most to Credo Technology Group in Q2 2026, an estimated $476M increase.
- Jennison Associates's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.98B.
- Jennison Associates fully exited Gilead Sciences in Q2 2026, selling an estimated $176M.
- Jennison Associates's ten largest holdings make up 45% of its $167B portfolio in Q2 2026.
- Jennison Associates opened 79 new positions and closed 74 in Q2 2026.
- Jennison Associates's portfolio value rose 15% quarter-over-quarter to $167B.
Based on Jennison Associates's 13F filing for Q2 2026, filed 3 Aug 2026.